share_log

藥明生物：(1) 建議重選退任董事(2) 建議修訂現有組織章程大綱及細則(3) 建議授出發行股份及購回股份的一般授權及(4) 股東週年大會通知

WUXI BIO: (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS(2) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUMAND ARTICLES OF ASSOCIATION(3) PROPOSED GRANT OF GENERAL MANDATESTO ISSUE SHARES AND TO REPURCHASE SHARESAND(4) NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  May 24 18:34
Summary by Futu AI
藥明生物技術有限公司將於2024年6月19日舉行股東週年大會，地點為中國上海市自由貿易試驗區基隆路28號上海外高橋喜來登酒店。會議將討論包括重選退任董事、修訂組織章程大綱及細則、授出發行股份及購回股份的一般授權等議題。股東將審議並投票決定是否接納2023年度經審核財務報表及董事會報告，以及是否續聘德勤會計師行為核數師。此外，股東將就是否授權董事會在未來一年內購回不超過已發行股份總數10%的股份作出決定。會議通知及相關文件已於公司網站及香港交易及結算所有限公司網站公布。
藥明生物技術有限公司將於2024年6月19日舉行股東週年大會，地點為中國上海市自由貿易試驗區基隆路28號上海外高橋喜來登酒店。會議將討論包括重選退任董事、修訂組織章程大綱及細則、授出發行股份及購回股份的一般授權等議題。股東將審議並投票決定是否接納2023年度經審核財務報表及董事會報告，以及是否續聘德勤會計師行為核數師。此外，股東將就是否授權董事會在未來一年內購回不超過已發行股份總數10%的股份作出決定。會議通知及相關文件已於公司網站及香港交易及結算所有限公司網站公布。
Pharmaceutical Biotechnology Co., Ltd. will hold its Annual General Meeting on June 19, 2024 at the Sheraton Shanghai Outer Takao Hotel, No. 28 Keelung Road, Shanghai, Free Trade Pilot Zone, Shanghai, China. THE MEETING WILL DISCUSS ISSUES INCLUDING RE-ELECTION OF RETIRING DIRECTORS, REVISING THE ORGANIZATION'S ARTICLES OF ASSOCIATION AND RULES, GRANTING GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES. Shareholders will review and vote to decide whether to accept the 2023 audited financial statements and the Board's reports and whether to renew the appointment of Takhine Accounting Practitioner as an Auditor. In addition, shareholders will decide whether to authorize the Board of Directors to repurchase shares not exceeding 10% of the total issued shares within the next year. The Notice of Meeting and related documents have been published on the Company's website and on the Hong Kong Trading and Settlement Limited website.
Pharmaceutical Biotechnology Co., Ltd. will hold its Annual General Meeting on June 19, 2024 at the Sheraton Shanghai Outer Takao Hotel, No. 28 Keelung Road, Shanghai, Free Trade Pilot Zone, Shanghai, China. THE MEETING WILL DISCUSS ISSUES INCLUDING RE-ELECTION OF RETIRING DIRECTORS, REVISING THE ORGANIZATION'S ARTICLES OF ASSOCIATION AND RULES, GRANTING GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES. Shareholders will review and vote to decide whether to accept the 2023 audited financial statements and the Board's reports and whether to renew the appointment of Takhine Accounting Practitioner as an Auditor. In addition, shareholders will decide whether to authorize the Board of Directors to repurchase shares not exceeding 10% of the total issued shares within the next year. The Notice of Meeting and related documents have been published on the Company's website and on the Hong Kong Trading and Settlement Limited website.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.